MERONI, MARINA
MERONI, MARINA
DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE
Abstract 7199: The retinoid X receptor (RXR) agonist IRX4204 potentiates the efficacy of trabectedin and pioglitazone in myxoid liposarcoma preclinical models
2024 Meroni, M; Craparotta, I; Mirimao, F; Panini, N; Ubezio, P; Bello, E; Renne, S; D'Incalci, M; Frapolli, R
Distribution of pamiparib, a novel inhibitor of poly(ADP-ribose)-polymerase (PARP), in tumor tissue analyzed by multimodal imaging
2024 Morosi, L; Timo, S; Amodeo, R; Lupi, M; Meroni, M; Bello, E; Frapolli, R; Martano, G; D'Incalci, M
Induction of adipocytic differentiation in myxoid liposarcoma: new approaches to improve the effectiveness of the available therapies
2024 Meroni, M; Craparotta, I; Mannarino, L; Zadro, R; Morosi, L; Matteo, C; Bello, E; Ubezio, P; Zucchetti, M; Renne, S; D’Incalci, M; Frapolli, R
Mechanism of efficacy of trabectedin against myxoid liposarcoma entails detachment of the FUS-DDIT3 transcription factor from its DNA binding sites
2024 Craparotta, I; Mannarino, L; Zadro, R; Ballabio, S; Marchini, S; Pavesi, G; Russo, M; Renne, S; Meroni, M; Ponzo, M; Bello, E; Sanfilippo, R; Casali, P; D'Incalci, M; Frapolli, R
MSIpixel: a fully automated pipeline for compound annotation and quantitation in mass spectrometry imaging experiments
2024 Morosi, L; Miotto, M; Timo, S; Carloni, S; Bruno, E; Meroni, M; Menna, E; Lodato, S; Rescigno, M; Martano, G
Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells
2023 Russo, M; Panini, N; Fabbrizio, P; Formenti, L; Becchetti, R; Matteo, C; Meroni, M; Nastasi, C; Cappelleri, A; Frapolli, R; Nardo, G; Scanziani, E; Ponzetta, A; Rosa Bani, M; Ghilardi, C; Giavazzi, R
Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli‐Responsive Nanocages
2023 Sancho‐albero, M; Facchetti, G; Panini, N; Meroni, M; Bello, E; Rimoldi, I; Zucchetti, M; Frapolli, R; De Cola, L
The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma
2023 Meroni, M; Mirimao, F; Craparotta, I; Panini, N; Ubezio, P; Bello, E; D’Incalci, M; Frapolli, R
The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma.
2023 Meroni, M; Bello, E; Cetti, F; Mirimao, F; Craparotta, I; Panini, N; Ubezio, P; D’Incalci, M; Frapolli, R
Corrigendum to “Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma” [Genomics Volume 113, Issue 5, September 2021, Pages 3439–3448] (Genomics (2021) 113(5) (3439–3448), (S0888754321003062), (10.1016/j.ygeno.2021.07.028))
2022 Mannarino, L; Craparotta, I; Ballabio, S; Frapolli, R; Meroni, M; Bello, E; Panini, N; Callari, M; Sanfilippo, R; Casali, P; Barisella, M; Fabbroni, C; Marchini, S; D'Incalci, M
Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice
2022 Ceruti, T; D’Alessandris, Q; Frapolli, R; Gopalakrishnan, J; Buccarelli, M; Meroni, M; Lauretti, L; Ricci-Vitiani, L; Pallini, R; Zucchetti, M
Establishment and characterization of a new panel of uterine leiomyosarcoma patient-derived xenograft models
2022 Meroni, M; Craparotta, I; Mannarino, L; Barbera, M; Bello, E; Cavallaro, U; Bertalot, G; Lorenzo Renne, S; D’Incalci, M; Frapolli, R
Pharmacokinetic evaluation of trabectedin and pioglitazone combination in myxoid liposarcoma patient-derived xenografts.
2022 Meroni, M; Matteo, C; Ceruti, T; Morosi, L; Zucchetti, M; Sanfilippo, R; Casali, P; D’Incalci, M; Frapolli, R
Pharmacokinetics of the combination of trabectedin and pioglitazone in myxoid liposarcoma patient-derived xenograft models
2022 Meroni, M; Ceruti, T; Morosi, L; Matteo, C; Zucchetti, M; Sanfilippo, R; Casali, P; Pilotti, S; D’Incalci, M; Frapolli, R
Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imaging
2022 Morosi, L; Matteo, C; Meroni, M; Ceruti, T; Fuso Nerini, I; Bello, E; Frapolli, R; D'Incalci, M; Zucchetti, M; Davoli, E
Betulinic acid and its spray dried microparticle formulation: In vitro PDT effect against ovarian carcinoma cell line and in vivo plasma and tumor disposition
2021 Serain, A; Morosi, L; Ceruti, T; Matteo, C; Meroni, M; Minatel, E; Zucchetti, M; Salvador, M
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy
2021 Belgiovine, C; Frapolli, R; Liguori, M; Digifico, E; Colombo, F; Meroni, M; Allavena, P; D'Incalci, M
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma
2021 Mannarino, L; Craparotta, I; Ballabio, S; Frapolli, R; Meroni, M; Bello, E; Panini, N; Callari, M; Sanfilippo, R; Casali, P; Barisella, M; Fabbroni, C; Marchini, S; D'Incalci, M
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
2021 Morosi, L; Meroni, M; Ubezio, P; Fuso Nerini, I; Minoli, L; Porcu, L; Panini, N; Colombo, M; Blouw, B; Kang, D; Davoli, E; Zucchetti, M; D'Incalci, M; Frapolli, R